Related Experiment Video
Updated: May 28, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases
Joshua A Smith1, Arabinda Das, Swapan K Ray
1Division of Neurology, Department of Neurosciences, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 309 CSB, P.O. Box 250606, Charleston, SC 29425, USA.
Abstract:
Microglia are activated in response to a number of different pathological states within the CNS including injury, ischemia, and infection. Microglial activation results in their production of pro-inflammatory cytokines such as IL-1, IL-6, and TNF-α. While release of these factors is typically intended to prevent further damage to CNS tissue, they may also be toxic to neurons and other glial cells. Mounting evidence indicates that chronic microglial activation may also contribute to the development and progression of neurodegenerative disorders. Unfortunately, determining the role of pro-inflammatory cytokines in these disorders has been complicated by their dual roles in neuroprotection and neurodegeneration. The purpose of this review is to summarize current understanding of the involvement of cytokines in neurodegenerative disorders and their potential signaling mechanisms in this context. Taken together, recent findings suggest that microglial activation and pro-inflammatory cytokines merit interest as targets in the treatment of neurodegenerative disorders.
Insights
Microglia activation releases pro-inflammatory cytokines, which can harm neurons. Targeting these cytokines may offer new treatments for neurodegenerative disorders.
Area of Science:
- Neuroscience
- Immunology
Background:
- Microglia, the central nervous system's immune cells, activate during pathological states like injury and infection.
- Activated microglia release pro-inflammatory cytokines (e.g., IL-1, IL-6, TNF-α), which have dual roles in neuroprotection and neurotoxicity.
- Chronic microglial activation is increasingly implicated in the development and progression of neurodegenerative disorders.
Purpose of the Study:
- To review the current understanding of cytokine involvement in neurodegenerative disorders.
- To explore the potential signaling mechanisms of cytokines in the context of neurodegeneration.
Main Methods:
- Literature review of studies on microglia, cytokines, and neurodegenerative diseases.
- Analysis of research on cytokine signaling pathways relevant to neuronal health and disease.
Main Results:
- Pro-inflammatory cytokines released by activated microglia can be toxic to neurons, complicating their role in CNS pathology.
- Evidence suggests a significant contribution of chronic microglial activation and associated cytokines to neurodegenerative processes.
- The dual neuroprotective and neurodegenerative roles of cytokines present therapeutic challenges.
Conclusions:
- Microglial activation and the resulting pro-inflammatory cytokine milieu are critical factors in neurodegenerative disorders.
- Cytokines and microglial pathways represent promising therapeutic targets for treating neurodegenerative diseases.
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Parkinson Disease ll: Pathophysiology
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Bacterial Meningitis II: Pathophysiology
Inflammatory Bowel Disease III: Crohn's Disease
Inflammation

